HAEGTFTSD acetate(926018-45-3 free base)
Code | Size | Price |
---|
TAR-TP1452L1-1mg | 1mg | £284.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1452L1-5mg | 5mg | £507.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1452L1-10mg | 10mg | £732.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1452L1-25mg | 25mg | £1,260.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1452L1-50mg | 50mg | £1,854.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
TAR-TP1452L1-100mg | 100mg | £2,745.00 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Special offer! Add £1 to your order to get a TargetMol CCK-8 Kit. Read more here. |
Quantity:
Prices exclude any Taxes / VAT
Overview
Regulatory Status: RUO
Shipping:
cool pack
Storage:
-20℃
Images
Documents
Further Information
Bioactivity:
HAEGTFTSD acetate is the first N-terminal 1-9 residues of GLP-1 peptide.The GLP-1 (7-36) amide is a product of the preproglucagon gene, which is secreted from intestinal L-cells, in response to the ingestion of food.
CAS:
TP1452L1
Formula:
C42H61N11O19
Molecular Weight:
1024.01
Pathway:
GPCR/G Protein
Purity:
0.98
SMILES:
O=C([C@H](CC1=CC=CC=C1)NC([C@@]([H])(NC(CNC([C@@H](NC([C@@H](NC([C@H](CC2=CN=CN2)N)=O)C)=O)CCC(O)=O)=O)=O)[C@@H](C)O)=O)N[C@H](C(N[C@H](C(N[C@@H](CC(O)=O)C(O)=O)=O)CO)=O)[C@@H](C)O.CC(O)=O
Target:
Glucagon Receptor
References
Rajesh BahekarMukul R. JainPankaj R. Patel. Short chain peptidomimetics based orally active glp 1 agonist and glucagon receptor antagonist.US20120264685